Glucose-Insulin-Potassium Solution Protects Ventricular Myocytes of Neonatal Rat in an In Vitro Coverslip Ischemia/Reperfusion Model

다국어 초록 (Multilingual Abstract)

Background and Objectives: The benefit of high glucose-insulin-potassium (GIK) solution in clinical applications is controversial. We established a neonatal rat ventricular myocyte (NRVM) in vitro coverslip ischemia/reperfusion (I/R) model and investigated the effects of GIK solution on suppressing reactive oxygen species (ROS) and upregulating O -GlcNacylation, which protects cells from ischemic injury.
Materials and Methods: NRVMs were isolated from postnatal day 3–4 Sprague–Dawley rat pups and grown in Dulbecco’s modified Eagle’s medium containing high glucose (4.5 g/L), fetal bovine serum, and penicillin/streptomycin. The effects of the GIK solution on ROS production, apoptosis, and expression of O -GlcNAc and O -GlcNAc transferase (OGT) were investigated in the coverslip I/R model.
Results: Covering the 24-well culture plates for 3 hr with 12 mm diameter coverslips resulted in the appropriate ischemic shock. Glucose and insulin synergistically reduced ROS production, protected NRVM dose-dependently from apoptosis, and altered O -GlcNAc and OGT expression.
Conclusion: The high GIK solution protected NRVM from I/R injury in vitro by reducing ROS and altering O- GlcNacylation.

참고문헌 (Reference)

1 Ngoh GA, "Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury" 104 : 41-49, 2009

2 Laybutt DR, "Selective chronic regulation of GLUT1 and GLUT4 content by insulin, glucose and lipid in rat cardiac muscle in vivo" 273 : H1309-H1316, 1997

3 Oliver MF, "Relation between serum-freefatty acids and arrhythmias and death after acute myocardial infarction" 1 : 710-714, 1968

4 Darley-Usmar VM, "Protein O-linked β-Nacetylglucosamine:a novel effector of cardiomyocyte metabolism and function" 52 : 538-549, 2012

5 Murry CE, "Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium" 74 : 1124-1136, 1986

6 Jovic M, "Preconditioning with glucose-insulin-potassium solution and restoration of myocardial function during coronary surgery" 28 : 262-270, 2009

7 Thibault H, "Postconditioning the human heart" 37 : 19-22, 2007

8 Rohr S, "Patterned growth of neonatal rat heart cells in culture. Morphological and electrophysiological characterization" 68 : 114-130, 1991

9 Rasoul S, "One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II" 122 : 52-55, 2007

10 Hart GW, "O-GlcNAcylation of key nuclear and cytoskeletal proteins: reciprocity with O-phosphorylation and putative roles in protein multimerization" 6 : 711-716, 1996

11 Ngoh GA, "Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition" 45 : 313-325, 2008

12 Yellon DM, "Myocardial reperfusion injury" 357 : 1121-1135, 2007

13 Ji L, "Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress" 298 : E871-E880, 2010

14 Obeid AI, "Influence of glucose, insulin, and potassium on vulnerability to ventricular fibrillation in the canine heart" 43 : 601-608, 1978

15 Brown MJ, "Hypokalemia from beta2-receptor stimulation by circulating epinephrine" 309 : 1414-1419, 1983

16 Diaz R, "Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction" 298 : 2399-2405, 2007

17 Grossman AN, "Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart" 127 : 1040-1048, 2013

18 Howell NJ, "Glucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the Hypertrophy, Insulin, Glucose and Electrolytes (HINGE) trial" 123 : 170-177, 2011

19 Apstein CS, "Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial" 96 : 1074-1077, 1997

20 Champattanachai V, "Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc" 292 : C178-C187, 2007

21 Carbó R, "Effects of polarizing solution on glucose uptake of rat oxygenated or hypoxic ventricular myocytes" 30 : 64-71, 2003

22 Krljanac G, "Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy" 96 : 1053-1058, 2005

23 Oliver EMF, "Effects of glucose and fatty acids on myocardial ischemia and arrhythmias" 343 : 155-158, 1994

24 Sodi-Pallares D, "Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report" 9 : 166-181, 1962

25 Mehta SR, "Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial" 293 : 437-446, 2005

26 Zachara NE, "Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells" 279 : 30133-30142, 2004

27 Pitts KR, "Coverslip hypoxia: a novel method for studying cardiac myocyte hypoxia and ischemia in vitro" 287 : H1801-H1812, 2004

28 Yusuf S, "Challenges in the conduct of large simple trials of important generic questions in resource-poor settings:the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction" 148 : 1068-1078, 2004

29 Cave AC, "ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate" 101 : 2090-2096, 2000

30 문일수, "A Simple Method for Combined Fluorescence In Situ Hybridization and Immunocytochemistry" 한국분자세포생물학회 24 (24): 76-82, 2007